SwePub
Sök i LIBRIS databas

  Utökad sökning

onr:"swepub:oai:gup.ub.gu.se/53347"
 

Sökning: onr:"swepub:oai:gup.ub.gu.se/53347" > Oral tolerization w...

  • Stanford, M. (författare)

Oral tolerization with peptide 336-351 linked to cholera toxin B subunit in preventing relapses of uveitis in Behcet's disease.

  • Artikel/kapitelEngelska2004

Förlag, utgivningsår, omfång ...

  • 2004-06-10
  • Oxford University Press (OUP),2004

Nummerbeteckningar

  • LIBRIS-ID:oai:gup.ub.gu.se/53347
  • https://gup.ub.gu.se/publication/53347URI
  • https://doi.org/10.1111/j.1365-2249.2004.02520.xDOI

Kompletterande språkuppgifter

  • Språk:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:ref swepub-contenttype
  • Ämneskategori:art swepub-publicationtype

Anmärkningar

  • Behcet's disease (BD) specific peptide (p336-351) was identified within the human 60 kD heat shock protein (HSP60). Oral p336-351 induced uveitis in rats which was prevented by oral tolerization with the peptide linked to recombinant cholera toxin B subunit (CTB). This strategy was adopted in a phase I/II clinical trial by oral administration of p336-351-CTB, 3 times weekly, followed by gradual withdrawal of all immunosuppressive drugs used to control the disease in 8 patients with BD. The patients were monitored by clinical and ophthalmological examination, as well as extensive immunological investigations. Oral administration of p336-351-CTB had no adverse effect and withdrawal of the immunosuppressive drugs showed no relapse of uveitis in 5 of 8 patients or 5 of 6 selected patients who were free of disease activity prior to initiating the tolerization regimen. After tolerization was discontinued, 3 of 5 patients remained free of relapsing uveitis for 10-18 months after cessation of all treatment. Control of uveitis and extra-ocular manifestations of BD was associated with a lack of peptide-specific CD4+ T cell proliferation, a decrease in expression of TH1 type cells (CCR5, CXCR3), IFN-gamma and TNF-alpha production, CCR7+ T cells and costimulatory molecules (CD40 and CD28), as compared with an increase in these parameters in patients in whom uveitis had relapsed. The efficacy of oral peptide-CTB tolerization will need to be confirmed in a phase III trial, but this novel strategy in humans might be applicable generally to autoimmune diseases in which specific antigens have been identified.

Ämnesord och genrebeteckningar

  • Adjuvants
  • Immunologic
  • administration & dosage
  • Administration
  • Oral
  • Adult
  • Antigens
  • CD
  • immunology
  • Behcet Syndrome
  • complications
  • immunology
  • CD4-Positive T-Lymphocytes
  • Cell Division
  • immunology
  • Cholera Toxin
  • administration & dosage
  • Humans
  • Immune Tolerance
  • Interferon Type II
  • immunology
  • Male
  • Middle Aged
  • Peptide Fragments
  • Phenotype
  • Receptors
  • Chemokine
  • immunology
  • T-Lymphocytes
  • immunology
  • Th1 Cells
  • immunology
  • Tumor Necrosis Factor-alpha
  • immunology
  • Uveitis
  • complications
  • immunology
  • prevention & control

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Whittall, T (författare)
  • Bergmeier, L A (författare)
  • Lindblad, Marianne,1941Gothenburg University,Göteborgs universitet,Institutionen för medicinsk mikrobiologi och immunologi,Institute of Medical Microbiology/Immunology(Swepub:gu)xlimar (författare)
  • Lundin, Samuel B,1970Gothenburg University,Göteborgs universitet,Institutionen för medicinsk mikrobiologi och immunologi,Institute of Medical Microbiology/Immunology(Swepub:gu)xlusam (författare)
  • Shinnick, T (författare)
  • Mizushima, Y (författare)
  • Holmgren, Jan,1944Gothenburg University,Göteborgs universitet,Institutionen för medicinsk mikrobiologi och immunologi,Institute of Medical Microbiology/Immunology(Swepub:gu)xholja (författare)
  • Lehner, T. (författare)
  • Göteborgs universitetInstitutionen för medicinsk mikrobiologi och immunologi (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:Clinical and experimental immunology: Oxford University Press (OUP)137:1, s. 201-80009-91041365-2249

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy